Leah Carrington, APRN
Family · Rogers, ARNPI 1629453030
Payments from drug & device makers
What this record shows
This record is dominated by other: $1,619,276 of the $1,619,751 with a category attached, or 100.0%. Skye Orthobiologics LLC accounts for 100.0% of it on its own, with 10 other manufacturers making up the rest. 2024 is the largest year on record at $1,619,310, more than ten times the $14 reported in 2021. Among family clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 17 payments — averaging $95,279 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Skye Orthobiologics LLC$1.6M
- Dexcom, Inc.$138
- Abbott$118
- KCI USA, Inc.$50
- Smith+Nephew$44
- Lundbeck LLC$40
- plus $86 from 5 others
What the payments were for
- Food & beverage$4760%
- Other$1,619,276100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Skye Orthobiologics LLC | 1 | $1,619,276 |
| Dexcom, Inc. | 2 | $138 |
| Abbott | 2 | $118 |
| KCI USA, Inc. | 3 | $50 |
| Smith+Nephew | 2 | $44 |
| Lundbeck LLC | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Convatec Inc. | 1 | $19 |
| Insulet Corporation | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Galderma Laboratories, L.p. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,619,751 in reported general payments places this provider in the 95th percentile of 2,103 family providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tresiba Flextouch U-200Insulin Degludec | 13 | $11,850 |
| Fluticasone Propionate | 11 | $213 |
Paid to pharmacies, not to this prescriber.
Other family in Rogers
- Katiutschka ReyesRogers$8K
- Nina CopelandFort Smith$207K
- Stefanie BrackinJonesboro$51K
- Amanda DavisFort Smith$46K
- Allison HittManila$40K
- Kimberly GatesNorth Little Rock$31K
- Meghan MallettConway$25K
- Anthony EcholsLittle Rock$25K
- Shelby CochranFayetteville$23K
- Michael StirlingLittle Rock$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.